Advanced Proteome Therapeutics

Advanced Proteome Therapeutics Corporation (APC) is advancing a site-specific protein modification technology platform to enable the development of superior protein therapeutics. APC is applying its scientific expertise and proprietary technology to pave the way towards next generation antibody conjugates, by advancing a site-selective labeling technology platform featuring Universal Antibody ConnectorsTM (UAC).  Through academic and industrial partnerships, APC is establishing a discovery stage product pipeline, including proprietary antibody drug conjugates against cancer targets, which the company will either partner following establishing discovery proof of concept or take into the clinic, as appropriate.

Focus area
Commencement date